Public health officials in Pennsylvania won't say how they'd handle a $500M cut sought by Trump admin
Pennsylvania health officials are facing down a potential $500 million loss of federal funding, but are tight-lipped about which programs and how many people might be affected by the Trump administration's decision.
The funding helps Pennsylvania purchase and administer vaccines, monitor the spread of infectious diseases like measles and influenza, and contact people who might have been exposed to dangerous pathogens.
'We're the only organization who does that in Chester County,' said Jeanne Franklin, director of the health department there.
She was one of the few local health officials contacted by Spotlight PA who was willing to speak on the record about how the money keeps Pennsylvanians healthy and safe from communicable illness.
In late March, the U.S. Department of Health and Human Services issued notices terminating $11 billion in grants to state and local health departments nationwide. The grants were created to help these agencies during the COVID-19 pandemic, but the Trump administration says they are obsolete.
Pennsylvania and 22 other states have sued to keep the funding, arguing Congress intended the money to be a 'wide-ranging' investment in public health beyond the pandemic. In addition to disease surveillance, the commonwealth has used the money for addiction treatment, childhood vaccinations, and services at community health centers.
The cuts are currently blocked as a federal judge reviews the suit, and Pennsylvania officials warn of damage to the public health system if the clawbacks are allowed.
The state health department declined to speak with Spotlight PA about how it uses the funding and whether the money could be replaced. A spokesperson said in a statement that it 'is analyzing potential impacts,' and that so far 'the actions at HHS have not led to any furloughs or terminations of full-time federally-funded employees within the Department.'
Exactly how Pennsylvanians would be affected by the loss of the money is hard to parse without input from the state health department, which receives the federal grants, and then passes a portion of the money on to county and city governments.
One public health worker, who was granted anonymity because they are not authorized to speak with the media, said leadership at their agency fears retaliation from the Trump administration. In recent months, the administration has slashed programs and personnel.
Of the 10 Pennsylvania public health agencies contacted by Spotlight PA, just two would speak about which services could be at risk.
Franklin of Chester County said that one way her agency uses federal funding is to pay the salaries of most of its disease investigation and surveillance staff.
If HHS yanks these grants, Franklin said, Chester County will have to pull back on contact tracing and analyzing data. That work allows her staff to determine which communities are most vulnerable to infectious disease outbreaks and then direct help their way.
Ronnie Das, public information officer for the Allegheny County Health Department, said the agency 'would cut programs' if it loses the federal funds, but would not go into further detail while the suit is pending.
But he added that money inevitably shapes what services the county can provide. 'It's not like we have this unlimited pot.'
Because the goal of public health is prevention, one measure of success is the absence of a crisis. That can lead to complacency and is partly why the U.S. is grappling with a measles outbreak, said Maureen Lichtveld, a physician and dean of the University of Pittsburgh's School of Public Health.
Measles is extremely contagious, and although outbreaks are preventable if enough people are vaccinated, immunization rates across the country have fallen over the past decade.
'We let our guard down,' Lichtveld said.
Federal funding undergirds much of the public health system, which is a patchwork of state and local agencies with varying policies and resources.
Until COVID-19, that support had been drying up, a trend that started during the 2008 financial crisis, said Josh Michaud of the health policy research group KFF. This left public health authorities underfunded and overwhelmed at the onset of the pandemic.
Before at-home tests became available, for example, Pennsylvanians sometimes waited more than two weeks to learn if they were infected with COVID-19 because local agencies couldn't process such large volumes of samples.
The grants that HHS wants to rescind were designed to prevent that level of tumult during another pandemic, which epidemiologists warn is a serious possibility.
States' suit over the funding will probably make its way to the U.S. Supreme Court, said Allison Winnike of the Network for Public Health Law, a research and policy nonprofit .
It's normal for new administrations to create policies that reflect their political priorities or sunset programs they don't like. But in the past, states could trust new presidents to honor legal agreements signed by their predecessors. Winnike told Spotlight PA that this abrupt termination of grant contracts is shocking and unprecedented.
'The states should be very, very nervous,' she said.
Winnike, Michaud, and others who spoke with Spotlight PA said the timing of this attempted disinvestment in public health is troubling.
CDC data show that 11% of 800 people infected with measles this year have been hospitalized. As of April 18, two children in Texas have died, and a third death in New Mexico is under investigation. Other long-term health consequences include the risk of permanent brain damage and a depressed immune response to new infections.
Pennsylvania has so far had few cases. That might change, warned Lichtveld: The kindergarten vaccination rate for 44 of Pennsylvania's 67 counties is under the recommended threshold to prevent spread, meaning there are enough unvaccinated kids in these communities for a potential outbreak. Also, most counties in Pennsylvania don't have a local health department and instead rely on the state for disease surveillance, which is less comprehensive.
'You really need to have a continuous active surveillance system,' she said.
Other infectious diseases making comebacks include tuberculosis and pertussis, which is also known as whooping cough. Pennsylvania saw a 658% increase in whooping cough cases between 2023 and 2024.
Franklin said Chester County is in a much stronger position today to handle emerging diseases compared to March 2020. It has responded to nearly 30 measles exposures since the start of the year using the protocols it refined during the pandemic, she noted.
If these systems had been in place at the onset of the pandemic, Franklin said, the virus would have spread more slowly in Chester County, and resulted in fewer critically ill patients at a time when health systems were overwhelmed and rationing medical care.
Josh Maxwell, chair of the Chester County Board of Commissioners, noted that his county is one of Pennsylvania's wealthiest and has a growing tax base. If the HHS funding ends, he said Chester County would have to cut other parts of its budget to sustain its public health department.
'As difficult as it's going to be on us, it's going to be more difficult on our neighbors,' he said.
Michaud also noted that health departments with fewer resources will especially feel the crunch of funding cuts, and be forced to prioritize certain public health threats over others.
'More people might die. You might have more illnesses occurring in the community,' said Michaud. 'So it doesn't seem to support a vision for making America healthy again.'
If you learned something from this article, pay it forward and contribute to Spotlight PA at spotlightpa.org/donate. Spotlight PA is funded by foundations and readers like you who are committed to accountability journalism that gets results.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Boston Globe
20 minutes ago
- Boston Globe
Claiming to fight waste, Trump administration slashes potentially cost-saving research
Harvard researchers had spent five years and some $3.8 million from the National Institutes of Health trying to answer this question when Mueller heard that the study might never yield results. In May, amid a feud with the university, the Trump administration abruptly terminated the grant that was funding it with one year and some $734,000 still to go. Without that time and money, pulmonologist Mary Berlik Rice and her team couldn't collect the final bits of data or analyze what they'd found. The clinical trial needed outcomes from a minimum number of participants to be able to conclude anything with any statistical significance. Advertisement 'It's a waste,' said Mueller — of taxpayer money, of everyone's time, of blood and tissue samples. N. Mueller sat beside the air purifier he was loaned as part of the study, which may or may not be functional. Lucy Lu for STAT That alone might seem to conflict with President Trump's stated goal of fighting 'waste, fraud, and abuse.' But scientists and participants like Mueller see another irony. The entire premise of this sort of study is that it might curb future waste. Advertisement It's a pillar of public health: Healthier people cost less. Figure out what could keep them well, and the government money spent on the discovery may well be dwarfed by the amount saved in hospitalizations and prescriptions averted. One of the most famous examples involves central venous catheters, thin tubes that intensive care doctors put into a patient's neck, chest, or groin to give fluids and medications or to draw blood. Those lines allow access to the bloodstream — but also pose an infection risk, creating a conduit that bacteria can take from the outside world into the veins. Such complications were both scary and common. In the early 2000s, they killed some 28,000 American ICU patients and cost $2.3 billion dollars every year. But then in 2006, a paper came out showing that the infections were avoidable. Led by intensive care specialist Peter Pronovost, a team of researchers tried out a simple solution in Michigan hospitals, instituting a checklist of risk-reducing hacks. These included clinicians washing their hands before inserting central lines; cleaning the patient's skin with a disinfectant called chlorhexidine; wearing sterile hair-coverings, masks, gowns, and gloves; using blood vessels in the neck or chest rather than the groin; and taking out catheters when they were no longer needed. Duh, you might say. But the infection rate fell dramatically. Within 18 months, it was near zero, and the intervention was estimated to have saved $100 million and 1,500 lives. 'I don't know how to describe how jaw-dropping this was,' said Leora Horwitz, a hospitalist in New York who studies how health care can be improved. 'This was like a shockwave of a paper.' Advertisement Pronovost says none of that could have happened without a grant of $500,000 a year for two years from a federal bureau called the Agency for Healthcare Research and Quality, which is dedicated to improving the delivery of medical care to patients and represents about 0.04 percent of the government's spending on health care. 'AHRQ pays for itself over and over again with studies like that,' said Horwitz. But the agency hasn't been spared in the Trump administration's slashing of federal research funding and the employees who administer it. Over a third of its employees were laid off in April, and the administration said it would be merged with another office within the Department of Health and Human Services. The effects of such cutbacks have been felt in the last few weeks. 'As a result of recent reduction in force at HHS, AHRQ's grants management staff were separated from Federal service on July 14, 2025,' one of the agency's directors wrote in an email to recipients of a grant for training new researchers, 'We are currently unable to process grant awards.' Signage for the Department of Health and Human Services headquarters was seen on April 2 in Washington, D.C. Anna Moneymaker/Getty Pronovost, now the chief quality and clinical transformation officer for the University Hospitals Cleveland, worries about the agency's decimation. His landmark 2006 paper can seem almost dull. It was partially about handwashing reminders and antiseptic usage. It was neither rocket science, nor a blockbuster drug. Nor, for that matter, does it sound like the 'edge science.' But it worked. When Pronovost sees package-delivery companies providing nearly flawless services, he knows that doesn't happen by accident; it happens through a management system. Every time there's a breakdown in what's supposed to happen — a box falling off a conveyor belt, say — there's a notification and an action taken, and if an action isn't taken, then there's an escalation. That was how he helped reduce his hospitals' Medicare expenditures by around 30 percent in 2023, a model that might save estimated $250 billion if applied nationwide. Advertisement Duke University hematologist Charity Oyedeji is pursuing research into measuring and hopefully preventing the functional impairment of adults with sickle cell disease. It started when she noticed just how dramatically her patients' biological ages outstripped their chronological ones. A 50-year-old reported difficulty getting on and off the toilet. A 20-something told her it was hard to reach up and get cups from the cupboard. She wondered whether tailored-to-your-ability exercise programs that have been shown to reduce frailty in older adults might help these people, too. It could improve quality of life and save money at the same time. 'We're trying to intervene early so we can improve their health span,' said Oyedeji, who was speaking in her personal capacity and not on behalf of her employer. 'We want to increase the number of good years that they have.' Oyedeji was in the second year of five — and had spent $300,000 of the $750,000 the NIH had allotted her — when her grant was terminated in June, years before she'd be able to reach any helpful conclusions. When asked about the cancellation of Oyedeji's grant, an HHS spokesperson wrote that the study has 'value,' but that 'it was funded under an inappropriate and ideologically driven — rather than scientifically driven — DEI program under the Biden administration.' Advertisement Researchers don't want to see their work — and participants' time — go to waste. Rice, the Harvard pulmonologist, has been able to scrape together enough money from the university to answer only a third of the questions that the NIH funded her to address. Spending $3.8 million to study how air purifiers could improve a specific type of chronic obstructive pulmonary disease might sound like a lot — and yet the illness itself costs some $24 billion a year in the US, which includes $11.9 billion in prescription drug expenses and $6.3 billion in hospital stays. 'We're throwing a lot of drugs at this,' said Rice, 'but I've found in my prior work that this group is especially susceptible to air pollution, and that led me to propose this trial to see if we could prevent some of the noxious exposures that trigger this severe disease.' To Mueller, 65, the idea made sense. Regular oil changes are ultimately cheaper than needing to get your engine replaced. He didn't want his breathing to worsen if he could help it, but that wasn't why he'd signed up for this trial. He hoped that by giving his time and nasal tissue, the benefits might be multiplied, spread out among others with the same disease, such that the scarring in their lungs could be held at bay. Of course, there might not be any benefit. That was the whole point, the reason for the trial, for the $3.8 million and five years of work. The researchers would only know at the end — if there was an end.


San Francisco Chronicle
an hour ago
- San Francisco Chronicle
CDC shooter blamed COVID vaccine for depression; union demands statement against misinformation
A Georgia man who had blamed the COVID-19 vaccine for making him depressed and suicidal has been identified as the shooter who opened fire late Friday on the U.S. Centers for Disease Control and Prevention headquarters, killing a police officer. The 30-year-old suspect, who died during the incident, had also tried to get into the CDC's headquarters in Atlanta but was stopped by guards before driving to a pharmacy across the street and opening fire, a law enforcement official told The Associated Press on Saturday. The man, identified as Patrick Joseph White, was armed with five guns, including at least one long gun, the official said, speaking on condition of anonymity because they were not authorized to publicly discuss the investigation. A union representing workers at the CDC said the incident was not random and 'compounds months of mistreatment, neglect, and vilification that CDC staff have endured." It demanded federal officials condemn vaccine misinformation, saying it was putting scientists at risk. Here's what to know about the shooting and the continuing investigation: An attack on a prominent public health institution Police say White opened fire outside the CDC headquarters in Atlanta on Friday, leaving bullet marks in windows across the sprawling campus. At least four CDC buildings were hit, Director Susan Monarez said on X. DeKalb County Police Officer David Rose was mortally wounded while responding. Rose, 33, a former Marine who served in Afghanistan, had graduated from the police academy in March. White was found on the second floor of a building across the street from the CDC campus and died at the scene, Atlanta Police Chief Darin Schierbaum said. He added that 'we do not know at this time whether that was from officers or if it was self-inflicted.' The Georgia Bureau of Investigations said the crime scene was 'complex' and the investigation would take 'an extended period of time." CDC union calls condemnation of vaccine misinformation and tighter security The American Federation of Government Employees, Local 2883, said the CDC and leadership of the Department of Health and Human Services must provide a 'clear and unequivocal stance in condemning vaccine disinformation.' 'Their leadership is critical in reinforcing public trust and ensuring that accurate, science-based information prevails,' the union said. Fired But Fighting, a group of laid-off CDC employees has said HHS Secretary Robert F. Kennedy Jr. is directly responsible for the villainization of CDC's workforce through "his continuous lies about science and vaccine safety, which have fueled a climate of hostility and mistrust.' Kennedy reached out to staff on Saturday, saying 'no one should face violence while working to protect the health of others.' Thousands of people who work on critical disease research are employed on the campus. The union said some staff were huddled in various buildings until late at night, including more than 90 young children who were locked down inside the CDC's Clifton School. The union said CDC staff should not be required to immediately return to work after experiencing such a traumatic event. In a statement released Saturday, it said windows and buildings should first be fixed and made 'completely secure." 'Staff should not be required to work next to bullet holes,' the union said. 'Forcing a return under these conditions risks re-traumatizing staff by exposing them to the reminders of the horrific shooting they endured.' The union called for 'perimeter security on all campuses' until the investigation is fully completed and shared with staff. Shooter had fixation on COVID-19 vaccine White's father, who contacted police and identified his son as the possible shooter, said White had been upset over the death of his dog and also had become fixated on the COVID-19 vaccine, according to the law enforcement official. A neighbor of White told The Atlanta Journal-Constitution that White 'seemed like a good guy' but spoke with her multiple times about his distrust of COVID-19 vaccines in unrelated conversations. 'He was very unsettled, and he very deeply believed that vaccines hurt him and were hurting other people,' Nancy Hoalst, told the Atlanta newspaper. 'He emphatically believed that.'
Yahoo
an hour ago
- Yahoo
TruBridge Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
TruBridge (NASDAQ:TBRG) Second Quarter 2025 Results Key Financial Results Revenue: US$85.7m (up 1.2% from 2Q 2024). Net income: US$2.58m (up from US$4.83m loss in 2Q 2024). Profit margin: 3.0% (up from net loss in 2Q 2024). EPS: US$0.18 (up from US$0.34 loss in 2Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period TruBridge EPS Beats Expectations, Revenues Fall Short Revenue missed analyst estimates by 1.1%. Earnings per share (EPS) exceeded analyst estimates. Looking ahead, revenue is forecast to grow 3.9% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Healthcare Services industry in the US. Performance of the American Healthcare Services industry. The company's shares are down 7.9% from a week ago. Valuation Our analysis of TruBridge based on 6 different valuation metrics shows it might be undervalued. To access our thorough examination of analyst consensus click here and discover the expected future direction of the company. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio